TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
about
HATL5: a cell surface serine protease differentially expressed in epithelial cancersTMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisitionFunctional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.Host cell proteases: Critical determinants of coronavirus tropism and pathogenesisTMPRSS3 is a novel poor prognostic factor for breast cancerIdentification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemiaMatriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer.Mechanisms of hepatocyte growth factor activation in cancer tissues.Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.Phosphorylation of the type II transmembrane serine protease, TMPRSS13 in Hepatocyte Growth Factor Activator Inhibitor-1 and 2-mediated cell surface localization.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation modelRegulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.The somatic mutation landscape of premalignant colorectal adenoma.Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer.Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization.MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.
P2860
Q24329267-BC093C6E-D657-409D-8A65-C49D601AEDBEQ28506622-56B79362-3AEE-4EE6-BDE3-975577D6DE3AQ35145031-499AD8BF-B6B7-4429-AE62-A87A25FA17F1Q35735214-98A699B7-FFAD-43E4-9FC5-2A20ACE06BB6Q35854198-893321A9-9605-4DD8-B902-C48040849CD5Q36294464-FD2F0898-1FA2-41EE-AF36-009CD5402531Q37629000-0EE3F87C-508E-4365-9EEB-80953C02E5CAQ38255480-EB023E90-A62D-4AF8-A4AF-755CEB99F7D4Q38575459-3B085510-5F29-41DF-8792-5690B4668922Q38678138-072CD4B0-48C4-4D0C-8C97-F3CE65D687F4Q38746986-9C002E29-D107-474B-AA8E-29E7D811E005Q38890925-481A67AD-783A-4C48-B042-832D588F6161Q39074016-59AE23F3-3E2A-4CB9-BBB6-4D493C2469B5Q39224627-6D3CAB01-A94D-4A33-93B9-BEF4E44623D3Q39409341-3B88992C-D963-493D-80A9-E8A852B4E110Q39758360-633D46BD-748E-4142-9D59-0F5785C8600DQ40162596-DE1AA2DF-F1DC-4FBB-B15E-0D43A32FE786Q44806334-7991ABDE-DB8F-4744-B61D-0450245CB5D2Q51221442-0D9EEE7B-BA04-418D-8134-460F4F509C13Q51689102-1B7BA981-9B42-45A4-B4B8-AEBAD571BB66
P2860
TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
TMPRSS13, a type II transmembr ...... pro-hepatocyte growth factor.
@en
type
label
TMPRSS13, a type II transmembr ...... pro-hepatocyte growth factor.
@en
prefLabel
TMPRSS13, a type II transmembr ...... pro-hepatocyte growth factor.
@en
P2093
P2860
P1433
P1476
TMPRSS13, a type II transmembr ...... pro-hepatocyte growth factor.
@en
P2093
Minoru Kato
Naomi Kitamura
Takeshi Shimomura
Tomio Hashimoto
P2860
P304
P356
10.1111/J.1742-4658.2010.07894.X
P407
P577
2010-10-26T00:00:00Z